The effect of omega-3 in the prevention of cardiac complications after PCI
Not Applicable
- Conditions
- Chronic ischaemic heart disease.Atherosclerotic heart disease
- Registration Number
- IRCT2016072329035N1
- Lead Sponsor
- Ardabil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
patients who require elective PCI; patients with angiographic indications for PCI; patients with personal satisfaction conscious to taking part in the study .
Exclusion criteria: patients who require emergency PCI; renal insufficiency; treatment with anticoagulant drugs; myocarditis or myopericarditis; myopathies; infection and chemotherapy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Troponin I. Timepoint: Before PCI and 24 hours after PCI. Method of measurement: Blood test.;CK-MB. Timepoint: Before PCI and 24 hours after PCI. Method of measurement: Blood test.
- Secondary Outcome Measures
Name Time Method